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Abstract
Background: Studies examining the effects of therapeutic interventions after stroke often focus 
on changes in loss of body function/structure (impairment). However, improvements in activities 
limitations and participation restriction are often higher patient priorities, and the relationship that 
these measures have with loss of body function/structure is unclear.
Objective: This study measured gains across WHO International Classification of Function (ICF) 
dimensions and examined their interrelationships.
Methods: Subjects were recruited 11–26 weeks after hemiparetic stroke. Over a 3-week period, 
subjects received 12 sessions of intensive robot-based therapy targeting the distal arm. Each 
subject was assessed at baseline and 1-month after end of therapy.
Results: At baseline, subjects (n=40) were 134.7±32.4 (mean±SD) days post-stroke and had 
moderate-severe arm motor deficits (arm motor Fugl-Meyer score of 35.6±14.4) that were stable. 
Subjects averaged 2,579 thumb movements and 1,298 wrist movements per treatment session. 
After robot therapy, there was significant improvement in measures of body function/structure 
(Fugl-Meyer score) and activity limitations (Action Research Arm Test, Barthel Index, and Stroke 
Impact Scale-hand), but not participation restriction (Stroke Specific Quality of Life Scale). 
Furthermore, while the degree of improvement in loss of body function/structure was correlated 
with improvement in activity limitations, neither improvement in loss of body function/structure 
nor in activity limitations was correlated with change in participation restriction.
CORRESPONDING AUTHOR: Steven C. Cramer, MD, University of California, Los Angeles, 710 Westwood Plaza, Reed C239, Los 
Angeles, CA 90095-1769, Phone: (424) 522-7273, sccramer@mednet.ucla.edu. 
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Conclusions: After a three-week course of robotic therapy, there was improvement in body 
function/structure and activity limitations but no reduction in participation restriction.
Keywords
stroke; rehabilitation; outcomes research; recovery; clinical trials
INTRODUCTION
Stroke remains a leading cause of long-term disability worldwide1. Deficits in function of 
the upper extremity represent a significant contributor to decreased function and quality of 
life post-stroke2. Interventions such as constraint-induced movement therapy3 and robot-
assisted therapy4,5 have emerged as promising approaches to promote return of function 
beyond that which is regained during spontaneous recovery and from conventional 
rehabilitation. However, the degree to which specific interventions affect disability and 
improve function after stroke is still poorly understood6,7.
Numerous outcome measures are available that assess the effect of stroke across all 
dimensions of the World Health Organization (WHO) International Classification of 
Function, Disability, and Health (ICF)8,9, complicating selection of appropriate 
measurement tools when assessing novel rehabilitation-related interventions10,11. 
Assessments of stroke-related loss of body function/structure (function/structure, previously 
referred to as impairment) are often preferred given that these measurements are more 
objective and easier to define1,12. In contrast, measures of activity limitations (activity) and 
participation restriction (participation), while often higher patient priorities13,14, are 
frequently qualitative and rely on patient self-reporting, and are therefore less commonly 
used when assessing novel interventions.
In general, a limited relationship has been found across WHO ICF dimensions such as loss 
of function/structure and activity12,15,16, and data are conflicting regarding the degree of 
correlation that exists. For example, a meta-analysis of electromechanical and robot-assisted 
arm training described high quality evidence that such interventions improve outcomes in 
both function/structure and activity, but there was limited evaluation of effects on 
participation17. The Fugl-Meyer (FM) motor scale18,19, a commonly employed measure of 
function/structure, was shown to demonstrate robust correlation with the Action Research 
Arm Test (ARAT), a measure of activity, when performed by expert raters19. On the other 
hand, studies of constraint-induced movement therapy report discrepancies between 
treatment-related changes in function/structure when compared to activity20. Another report 
found that a majority of patients demonstrating no measurable upper extremity motor 
impairment in an assessment of function/structure continued to report deficits as measured 
by assessments of activity and participation21. This inconsistent relationship may be due to 
numerous factors having greater influence on outcome as one moves from measurements of 
function/structure to activity or participation16. For example, multiple studies have shown 
improvements in patients’ functional independence measure scores (FIM, a measure of 
activity) over the course of inpatient rehabilitation despite minimal change in FM total 
Wu et al. Page 2
Neurorehabil Neural Repair. Author manuscript; available in PMC 2020 December 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
score22 or NIHSS23 (both assessments of function/structure), potentially related to use of 
assistive devices or learning compensatory skills.
In the setting of a clinical trial on intensive robot-assisted therapy, the current study had two 
primary aims. First, the study aimed to provide a detailed assessment of the effect of robot-
assisted therapy across all ICF dimensions. Second, the study also aimed to assess the degree 
to which therapy-related improvements in function/structure were related to improvements 
in activity and participation. We hypothesized that robot-assisted therapy would result in 
clinically and statistically significant gains in function/structure with smaller gains in 
activity and participation.
METHODS
Subject enrollment
Forty-one individuals 11–26 weeks after stroke onset gave informed consent to participate in 
a longitudinal study of standardized intensive robot-assisted therapy targeting the distal arm 
(clinicaltrials.gov, ID# NCT01244243). In one individual, baseline imaging revealed an 
incidental finding that met exclusion criteria. Therefore, results represent the remaining 40 
eligible subjects. Neuroimaging data from a subset of these subjects have previously been 
reported24. Study procedures were approved by the University of California, Irvine 
Institutional Review Board.
Inclusion and exclusion criteria were designed to select for individuals with a wide range of 
motor deficits in whom spontaneous arm motor recovery had reached a plateau. All subjects 
met the following inclusion criteria: (1) age ≥18 years; (2) hemorrhagic or ischemic stroke 
with onset 11–26 weeks prior to enrollment; (3) residual arm motor deficits, defined as 
ARAT score <52 or 9-hole peg test score >25% longer in the affected compared to 
unaffected hand; and (4) preservation of voluntary movement in the distal upper extremity, 
as demonstrated by ≥5 degrees of active range of motion in the wrist or index finger 
metacarpophalangeal joint of the affected side. Individuals were excluded from the study if 
they had a contraindication to MRI, severe cognitive impairment (Mini Mental Status 
Examination, MMSE, score < 27), a comorbid diagnosis impacting the function of the 
affected upper extremity, or unstable arm motor status. Stable arm motor status was defined 
as change in FM score ≤2 points across two successive baseline assessments that spanned ≥1 
week prior to initiation of robot therapy. This was a single treatment-arm study, with no 
comparison or placebo group.
Robot therapy
Robot-assisted therapy consisted of 12 treatment sessions across 3 weeks. Sessions occurred 
4 days/week for 2 hours/day, totaling 24 total hours of delivered therapy. All subjects 
completed at least 11 of 12 prescribed robot therapy sessions. This robot has been previously 
described5 (Figure 1). In brief, the robotic device has 3 degrees-of-freedom, is 
pneumatically-actuated, and is back-driveable. The 3 degrees are rotational movement of the 
wrist, thumb, and fingers in the plane of gravity, with the fingers moving as a single unit 
about the metacarpophalangeal joint. Specifically, the device assists in power grip and 
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release movements in a pattern that combines wrist extension with hand grasp, then wrist 
flexion with hand release. Robot-assisted joint movement is achieved by a lever design, in 
which a pneumatic cylinder is mounted at the opposite end of a lever from the limb 
interface, with a revolute joint in between. Back-driveability of the robot permits the subject 
to freely drive movements when active assistance is not engaged.
At the start of each session, a trained therapist (licensed occupational therapist or physical 
therapist) assisted in robot adjustments to accommodate differences in hand sizes across 
subjects and to ensure maximal biomechanical advantages in robot-assisted movements. The 
therapist also determined the comfortable passive and active range of motion at each of the 
three degrees, for each subject, and adjusted the robot’s hard stops accordingly. Movement 
repetitions were calculated from each subject’s pre-treatment range of motion, such that a 
movement cycle was counted when measured active movement exceeded a preset threshold 
of the baseline active range of motion at a specified joint.
Each robot-assisted therapy session began with robot-assisted passive stretching, then grasp-
release exercises. A wide range of real objects was placed in the hand, and the subject was 
asked to describe features such as texture or temperature. Next, and occupying most of the 
session were repeated grasp-release movements of the affected hand coupled to video games 
(e.g., squeezed mustard onto a hot dog consumed by Homer Simpson, or hand closure in the 
robot squeezed a fire extinguisher to douse a forest fire, with approval of Smokey The Bear, 
Figure 1C). These games emphasized control of hand movement range, speed, and timing. 
For each movement, the subject-initiated hand grasp, and if the subject did not complete the 
full movement, the pneumatic cylinder was activated to assist in completing hand grasp. In 
most games, movement was initiated in response to a simple computer-generated cue; in 
others, movement onset time was self-initiated, in an attempt to activate supplementary 
motor area25; and in others, choice of movement was guided by cues that corresponded to 
regularly-changing rules displayed on the screen, in an attempt to activate dorsal premotor 
cortex26. The therapist was at the patient’s side at all times to monitor and adjust robot-
subject interface, clarify gameplay, and address any questions that arose. In total, the robot 
recorded an average of 11,278 finger movements, 28,970 thumb movements, and 15,759 
wrist movements across the 3 weeks of therapy; average movement repetitions per day were 
954 for finger movements, 2,579 for thumb movements, and 1,298 for wrist movements. For 
some games, hand grasp required movement of the fingers and thumb only, while other 
games required movement of the wrist and thumb. As a result, the number of movement 
repetitions was greatest for the thumb.
Study design
Clinical assessments were performed at three time points: (1) ≥2 weeks prior to therapy [first 
baseline visit], (2) ≥1 week prior to therapy and at least 7 days after first baseline visit 
[second baseline visit], and (3) 1 month following completion of therapy. Performance of 
two baseline assessments prior to initiation of therapy was done in order to ensure subjects 
had reached a stable plateau in motor recovery of the affected distal upper extremity.
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Clinical outcome measures
All clinical assessments were performed by one of two physical therapists blinded to the 
subjects’ performance during therapy. The primary outcome measures were the Upper 
Extremity FM Assessment18 and the ARAT27, which have good reliability, reproducibility, 
and responsiveness to therapy19.
Assessments were categorized per the ICF dimensions of stroke recovery8,28 as defined by 
the RehabMeasures Database at the Shirley Ryan AbilityLab (https://www.sralab.org/
rehabilitation-measures). Measures of loss of body function/structure were the FM arm 
motor scale, grip strength, and pinch strength. Measures of activity limitations were ARAT, 
Box and Blocks Test, Barthel Index29, and the Stroke Impact Scale30,31 hand motor domain 
(SIS-hand). One measure of participation restriction was used, the Stroke Specific Quality of 
Life Scale32 (SS-QOL). The FM, ARAT, and Box and Blocks Test were scored at both 
baseline visits. Due to logistical issues, the SS-QOL was added after the tenth subject was 
enrolled.
Statistical analysis
For FM, ARAT, and Box and Blocks assessments, evaluation of robot therapy-related 
improvement was calculated with respect to the mean of the two baseline assessments. For 
all other measures, therapy-related improvement was calculated with respect to scores at the 
first baseline visit.
Paired testing was used to determine the statistical significance of therapy-related 
improvement. Measures that were normally distributed or could be transformed to a normal 
distribution were evaluated using the paired t-test, while non-normally distributed measures 
were evaluated using the Wilcoxon signed-rank test. Effect size was determined using the 
Cohen’s d metric for parametric measures and the Mann-Whitney U Test for nonparametric 
measures. Bivariate analyses were used to determine the degree of correlation between the 
changes in clinical measures using Pearson’s correlation for normally distributed measures 
and Spearman’s rank correlation for non-normally distributed measures. All analyses were 
two-tailed with alpha=0.05, Bonferroni corrected, and were performed using MATLAB 
8.5.0 (Mathworks, Natick, MA).
RESULTS
Subject characteristics
Demographics for the 40 subjects are summarized in Table 1. Subjects were mainly right-
hand dominant. Across the 40 subjects, the index infarct was in the left hemisphere in 21 and 
in the right hemisphere in 19. Ten individuals had more than one infarct. There was 
significant variability in size and location of infarcts (33.1±50.0 cc, mean±SD). Mean time 
between the two baseline assessments was 15.6±6.0 days (range 7–30 days). FM, ARAT, 
and Box and Blocks Test scores did not change across the two baseline assessments 
(p>0.05). Baseline scores appear in Table 2.
Wu et al. Page 5
Neurorehabil Neural Repair. Author manuscript; available in PMC 2020 December 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Outcomes after robot therapy
Subjects demonstrated statistically significant improvement in all measures of function/
structure and activity after robot therapy, from baseline to the post-therapy assessment 
(Table 2). The group did not show statistically significant change in SS-QOL, the only 
measure of participation. Across all measures, the largest effect sizes were noted for 
improvement in FM (d=0.57), Box and Blocks Test (d=0.48), and ARAT (d=0.46); a smaller 
effect size was seen for SIS-hand (d=0.37).
Correlation across ICF dimensions
Correlations for improvements in measures both within and across ICF dimensions are 
detailed in Table 3. Briefly, modest correlations were demonstrated between measures 
within each ICF dimension. However, the strongest correlations were found between 
measures of function/structure and activity. For example, improvements in FM were robustly 
correlated with improvements in ARAT (Figure 2A, r=0.69, p<0.0001) and Box and Blocks 
Test (Figure 2B, r=0.55, p=0.0002). Similarly, improvement in grip strength was correlated 
with improvement in Box and Blocks Test score (r =0.52, p=0.0005). Change in SIS-hand, a 
patient-reported measure of activity, did not correlate with improvements in FM or ARAT.
Changes in SS-QOL were not correlated with improvements in any measure of function/
structure or activity, including FM, ARAT, and SIS-hand.
DISCUSSION
Stroke-related deficits in upper extremity function remain a significant contributor to 
disability worldwide, with persistent deficits directly linked to activity limitations, 
participation restriction, poorer quality of life, and decreased subjective well-being1,21,33. 
Novel interventions, including robot-assisted therapy, have been developed to reduce stroke-
related disability. However, available data provide a limited understanding of the degree to 
which such interventions produce changes across ICF dimensions. Furthermore, there have 
been limited studies that directly examine the degree to which treatment-related gains in one 
ICF dimension are associated with gains across other ICF dimensions.
The current study found that subjects who completed a course of robot-based therapy 
demonstrated statistically significant improvements in stroke-related loss of body function/
structure and activity limitations, but not in participation restriction. Specifically, robot-
assisted therapy was associated with statistically significant gains across all measures of 
function/structure and activity, including both primary endpoints: FM (a measure of 
function/structure) and ARAT (a measure of activity). Estimates of the minimal clinically 
important difference (MCID) for the FM and ARAT have been estimated to be 10% of the 
scale maximum18,34, or 6.6 and 5.7 points respectively. Using this estimate, 17.5% of the 
study patients achieved MCID on the FM, and 32.5% on the ARAT, after robot-assisted 
therapy. Lo et al4 have suggested that for some subjects with chronic stroke, gains below 
MCID might be clinically meaningful. SIS-hand, which is a patient-reported measure of 
activity, also showed a statistically significant improvement after therapy, though effect size 
was notably smaller. Improvements in measures of function/structure were robustly 
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correlated with measures of activity, consistent with prior studies that found measures of 
function/structure to be significantly correlated with measures of activity, including Barthel 
Index, FIM, and SIS-1635,36. Together, the current results provide an in-depth examination 
of the degree to which clinical improvements after robot-based therapy extend across ICF 
dimensions.
Current findings are similar to previously published large-scale clinical trials in which an 
experimental intervention produced significant gains in measures of function/structure and 
activity, but not in measures of participation3,37,38. This difficulty to generate changes in 
participation likely reflects both the multitude of factors that contribute to participation in 
society and the complex interaction of such factors1. Previous studies have identified 
demographic variables, socioeconomic status, injury characteristics, medical and psychiatric 
comorbidities, social support, and functional status as contributors to deficits in post-stroke 
participation2,39. Given that participation can be influenced by so many variables, including 
those related to both the function/structure and activity dimensions40, it may be that 
detection of meaningful improvements in participation requires a longer time period in order 
to develop and thus an extended follow-up period, consistent with the observation from 
longitudinal studies that quality of life after stroke can take months to years to manifest41. In 
line with this, Wolf and colleagues found initial changes in SIS functional domains were 
only followed by improvements in SIS participation domains after a period of 12–24 months 
beyond when the intervention was completed42.
The high number and density of movement repetitions provided by the robot represent 
several strengths of the current study. First, standardization of treatment by the robot 
minimizes variability in conventional rehabilitation interventions which could confound the 
relationship between improvements after robot-assisted therapy across ICF dimensions43. 
Second, robot-based interventions often deliver a higher intensity of movement repetitions 
compared to conventional interventions43,44. In one study, conventional therapist-
administered interventions provided an average of 32 repetitions/session45, which is too few 
movements to induce neural plasticity46 and an impediment to improving behavior, 
particularly in higher order ICF dimensions including participation47. In contrast, patients in 
the current study averaged 2,579 thumb movements and 1,298 wrist movements per 
treatment session, exceeding the 600–700 repetitions per day48 in rats and the 92449 
movements/day in primates considered necessary to realize functional benefits with stroke 
rehabilitation. Third, each hand movement in the robot was coupled to video games. Games 
promote patient involvement in health care50,51 and motivate patients to engage in enjoyable 
play behavior that involves therapeutically relevant movements52,53. Use of games alters 
cognitive context54 and, compared to rote movement repetition, increases activity in 
cognitive networks in patients with stroke55.
After robot-assisted therapy, improvements in function/structure and activity were not 
associated with improvements in participation. Recently published results from two large-
scale clinical trials also reported a dissociation between treatment-related motor gains and 
change in measures of participation16,38. Lang and colleagues38 found that while the 
majority of subjects reported overall perception of meaningful change with treatment, as a 
group they did not demonstrate statistically significant improvement in measures of 
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participation. A cross-sectional study31 comparing SIS with SS-QOL also reported 
significant dissociation, with SIS subscores being more responsive to treatment as compared 
to SS-QOL subscores. On the other hand, Roth and Lovell56 reported a correlation between 
FIM scores >80 at one year post-stroke and increased community/home participation as 
defined by the Frenchay Activities Index. Together, these results highlight an ongoing need 
for robust, responsive, and specific measures of participation, particularly when evaluating 
the effect of novel interventions for reducing stroke disability. Strikingly, in a review of the 
116 instruments on www.rehabmeasures.org28 designated for stroke, only 15 instruments 
were strictly participation measures. The overwhelming majority of those instruments assess 
only three or four items to characterize overall quality of life, and thus provide coarse 
gradation across patients. Underscoring the limited attention to participation in studies of 
stroke rehabilitation therapies, a report by Salter and colleagues showed only 25% of 
randomized controlled trials of stroke rehabilitation in the last four decades included an 
assessment of participation57. These prior studies indicate the ongoing interest and the 
paucity of knowledge regarding the translation between improvements in function/structure 
and participation, changes that are more clinically meaningful to patients.
Several limitations are associated with the current study. First, subjects were studied 11–26 
weeks post-stroke. As such, it is unknown the degree to which the current findings can be 
extended to patients who initiate therapy at an earlier or later time post-stroke. In addition, 
while the literature reports 95% of patients with upper extremity deficits reach recovery 
plateau by 11 weeks post-stroke58, the improvements demonstrated after robot-assisted 
therapy (Table 2) may not be entirely attributable to the robotic intervention and instead may 
be confounded by a degree of natural recovery. Any contributions of natural recovery to the 
current results are likely attenuated in this study, however, as serial baseline assessments 
indicated that subjects had reached stable arm motor status at the time of enrollment. The 
primary endpoint of the study was at one-month post therapy, which was an additional study 
limitation. It may be that any long-term changes in participation and their relationship over 
time59 with structure/function and activities, were not captured as a result of this one-month 
focus. Finally, reflecting the paucity of meaningful participation measures reported in the 
stroke literature, the SS-QOL was the only participation measure used in the current study. 
Although other measures of participation are available, the SS-QOL has been validated in 
stroke patients in multiple studies60,61 and includes measures of quality of life as they relate 
to upper extremity function, making it especially suited for the current study.
Though the generalizability of these results to robot-assisted therapy beyond the upper 
extremity is yet unknown, studies showing correlations between function/structure of the 
lower extremity62 and activity using the Barthel index35,62, SIS-1636, and FIM22,36 suggest 
that further studies in other key components of movement are warranted and may show 
similar relationships.
Conclusions
Novel interventions to reduce stroke disability are in development63. The current results 
demonstrate robot-assisted therapy, specifically, supports improvements in stroke-related 
loss of body function/structure, as well as activity limitations. The results also underscore 
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concerns regarding the incomplete relationships between therapy-related improvement in 
function/structure and activity (often the primary endpoints in clinical trials), and 
improvements in participation, which are often prioritized by patients1. Ultimately, this 
study highlights the need64 for further development of instruments that provide accurate, 
specific, reliable, reproducible, and granulated assessments of participation restriction after 
stroke.
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FIGURE 1. 
(A) Diagram of subject’s posture, relationship to robot, and relationship to computer 
monitor during therapy. (B) Demonstration of subject’s hand and arm interfacing with the 
robot. Arrowheads denote ulnar forearm rest. White asterisks indicate soft Velcro straps 
connecting the subject’s hand to the robot. (C) Example of virtual reality game, in which 
hand grasp turned on fire extinguisher while grasp release turned off fire extinguisher during 
Smokey the Bear game. Figure partially reprinted with permission from previously 
published material5.
Wu et al. Page 13
Neurorehabil Neural Repair. Author manuscript; available in PMC 2020 December 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
FIGURE 2. 
Scatterplot demonstrating the relationship between change in Upper Extremity Fugl-Meyer 
Assessment score and change in (A) Action Research Arm Test (r = 0.69, p < 0.0001) and 
(B) Box and Blocks Test (r = 0.55, p =0.0002). Change after robot-assisted therapy was 
calculated as the absolute change in score from baseline (mean of two assessments) to 1-
month post-therapy assessment.
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TABLE 1:
Subject demographics
Gender 11 F / 29 M
Age, mean (SD) 58.0 (13.7) years
Time since last stroke, mean (SD) 134.7 (32.4) days
Ethnicity Hispanic 3
Non-Hispanic or Latino 37
Race Asian 7
Black or African American 5
White 24
Co-morbid medical conditions Hypertension 21 N/ 19 Y
Hyperiipidemia 21 N / 19 Y
Diabetes meilitus 29 N / 11 Y
Atrial fibrillation 35 N / 5 Y
History of prior stroke 30 N/10Y
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TABLE 2:
Clinical assessments at baseline and post-treatment
Baseline mean (SD) Post-treatment mean (SD) Change mean (SD) Test statistiC† (p-value)
Measures of loss of body function/struclture
Fugl-Meyer 35.6 (14.4) 39.4 (15.0) 3.79 (3.32) 5.14
†
 (<0.0001)
Grip strength (kg) 6 (6.5) 8.2 (8.8) 2.25 (4.54) 3.86* (<0.0001)
Pinch strength (kg) 1.9 (1.7) 2.6 (2.1) 0.64 (1.06) 3.69* (<0.0001)
Measures of activity limitations
ARAT 25.1 (18.7) 29.2 (19.6) 4.11 (5.86) 4.10*(<0.0001)
Box and Blocks 13.2 (15.5) 17.0 (17.8) 3.81 (5.51) 4.29* (<0.0001)
Barthel Index 88.5 (9.1) 93.3 (8.1) 4.75 (6.2) 3.89
†
 (0.0001)
SIS-hand 2.08 (1.03) 2.6 (1.2) 0.47 (0.76) 3.28
†
 (0.0001)
Measures of participation restriction
SS-QOL 3.8 (0.57) 3.6 (0.6) 0.10
†
 (0.50) 1.08
†
 (0.29)
†
Student’s t-test t-Ratio is reported for normally distributed measures.
*
Wilcoxon signed-rank z-score is reported for non-normally distributed measures.
Neurorehabil Neural Repair. Author manuscript; available in PMC 2020 December 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Wu et al. Page 17
TABLE 3:
Correlations between clinical measures
Correlation coefficient P
Within ICF dimension correlations
Measures of loss of body function/structure (function/structure)
Fugl-Meyer Grip strength 0.26 0.11
Fugl-Meyer Pinch strength 0.34 0.03
Grip strength Pinch strength 0.50 0.001*
Measures of activity limitations (activity)
ARAT Box and Blocks 0.50 0.0009*
ARAT SIS-hand 0.21 0.20
Box and Blocks SIS-hand 0.41 0.008*
Across ICF dimension correlations
Function/structure Activity
Fugl-Meyer ARAT 0.69 < 0.0001*
Fugl-Meyer Box and Blocks 0.55 0.0002*
Fugl-Meyer SIS-hand 0.16 0.32
Grip strength ARAT 0.17 0.29
Grip strength Box and Blocks 0.52 0.0005*
Grip strength SIS-hand 0.24 0.13
Pinch strength ARAT 0.37 0.02
Pinch strength Box and Blocks 0.31 0.05
Pinch strength SIS-hand 0.35 0.03
Function/structure Participation
Fugl-Meyer SS-QOL 0.34 0.07
Grip strength SS-QOL 0.11 0.56
Pinch strength SS-QOL 0.12 0.51
Activity Participation
ARAT SS-QOL 0.24 0.20
Box and Blocks SS-QOL 0.32 0.08
SIS-hand SS-QOL 0.22 0.25
*
denotes correlations reaching statistical significance, with p<0.05, corrected for multiple comparisons
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